论文部分内容阅读
目的观察雾化吸入3%高渗氯化钠混合液体治疗毛细支气管炎的临床价值。方法将87例毛细支气管炎患者随机分为治疗组46例和对照组41例,两组均给予基础治疗,其中治疗组予以雾化吸入3%高渗氯化钠溶液、沙丁胺醇、盐酸氨溴索注射液组成的混合液体。对照组予以雾化吸入0.9%氯化钠溶液、沙丁胺醇、盐酸氨溴索注射液组成的混合液体,治疗至症情缓解,比较两组患者的治疗效果。结果治疗组总有效率为93.4%,对照组总有效率为85.3%,治疗组疗效明显优于对照组,差异有统计学意义(P<0.05)。结论 3%高渗氯化钠混合液体雾化吸入的方法治疗毛细支气管炎疗效显著,值得临床推广。
Objective To observe the clinical value of inhalation of 3% hypertonic sodium chloride mixed liquid in the treatment of bronchiolitis. Methods A total of 87 patients with bronchiolitis were randomly divided into treatment group (n = 46) and control group (n = 41). Both groups were given basic treatment. In the treatment group, inhalation of 3% hypertonic sodium chloride solution, salbutamol, ambroxol hydrochloride Injection of a mixture of liquid. The control group was nebulized inhalation of 0.9% sodium chloride solution, salbutamol, ambroxol hydrochloride mixture of liquid injection, treatment to ease the situation, the treatment effect of two groups were compared. Results The total effective rate was 93.4% in the treatment group and 85.3% in the control group. The curative effect in the treatment group was significantly better than that in the control group (P <0.05). Conclusion 3% hypertonic sodium chloride mixed liquid inhalation method for the treatment of bronchiolitis significant effect, worthy of clinical promotion.